# Levetiracetam for Seizure Prevention After Brain Tumor Surgery

> **NCT07239115** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 558 (estimated)

## Conditions studied

- Postoperative Seizures After Brain Tumor Surgery

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07239115
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-06
- **Target enrollment:** 558 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07239115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07239115, "Levetiracetam for Seizure Prevention After Brain Tumor Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07239115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*